Drug news
NICE recommends peginterferon alfa plus ribavirin for Hepatitis C
NICE has recommended peginterferon alfa in combination with ribavirin as an option for treating chronic Hepatitis C in children and young people. As a result, Roche's Pegasys (peginterferon alfa-2a) and MSD's ViraferonPeg (peginterferon alfa-2b) will become available as NHS treatments. Ribavirin is manufactured by Roche (Copegus) and MSD (Rebetol) and each product is indicated for the treatment of chronic Hepatitis C.